Lung Cancers Completed Phase 2 Trials for Ortataxel (DB11669)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00054314BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerTreatment